TriSalus Life Sciences, Inc. (TLSIW) Operating cash flow 2021–2025
TriSalus Life Sciences, Inc. (TLSIW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$18.0MFY2025 · since FY2021: -$1.7M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | +55.9% |
| FY2024 | -$40.8M | +19.2% |
| FY2023 | -$50.6M | -56.5% |
| FY2022 | -$32.3M | -1759.1% |
| FY2021 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice